ATLASVor Biopharma (VOR) earnings date: Nov 12, 2026
Vor Biopharma (VOR) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of -$0.81.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VOR
| Last price | $19.68 (-5.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Vor Biopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Vor Biopharma reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Vor Biopharma. You can switch it off at any time.
Alert me before VOR reportsFree to start. Creating an account takes under a minute.
VOR earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.81 |
| Last report | Oct 30, 2026 |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +5,183.7% |
| Average move around a report | ±10.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Vor Biopharma earnings history: last 6 reports
Vor Biopharma last reported on Oct 30, 2026: EPS of -$0.90 against an estimate of -$0.72.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 30, 2026 | -$0.72 | -$0.90 | – | – | – |
| Aug 11, 2026 | -$0.70 | -$0.80 | -14.3% | Miss | -4.4% |
| Jun 2, 2026 | $0.23 | $0.17 | -26.1% | Miss | -7.8% |
| May 13, 2026 | -$0.78 | -$0.73 | +6.4% | Beat | -8.5% |
| Mar 30, 2026 | -$1.19 | $307.53 | +25,940.0% | Beat | +23.2% |
| Dec 1, 2025 | $0.16 | $0.18 | +12.5% | Beat | -9.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VOR
See the fair value, the probability range and the earnings history of Vor Biopharma on its ATLAS page.
Vor Biopharma (VOR) stock analysisPlans from €3.99 a month.
Vor Biopharma earnings: frequently asked questions
When does Vor Biopharma (VOR) report earnings?
Vor Biopharma is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VOR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.81 per share (USD). Estimates can change before the report.
How often does VOR beat earnings estimates?
Of its last 5 reports with a recorded result, Vor Biopharma beat the EPS estimate 3 times; the average surprise was +5,183.7%. Past results do not predict the next one.
How much does VOR move around earnings?
Over its last 5 reports the stock moved an average of 10.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Vor Biopharma beat earnings estimates last quarter?
Vor Biopharma last reported on Oct 30, 2026: EPS of -$0.90 against an estimate of -$0.72.
How much does VOR usually move in a day?
On a normal trading day the ATLAS model puts VOR’s one-day range at about ±4.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer